| DNA purification and isolation using a solid-phase. TL Hawkins, T O'Connor-Morin, A Roy, C Santillan Nucleic acids research 22 (21), 4543, 1994 | 325 | 1994 |
| MR imaging of liver fibrosis: current state of the art SC Faria, K Ganesan, I Mwangi, M Shiehmorteza, B Viamonte, S Mazhar, ... Radiographics 29 (6), 1615-1635, 2009 | 290 | 2009 |
| Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma RF Hanna, VZ Miloushev, A Tang, LA Finklestone, SZ Brejt, RS Sandhu, ... Abdominal radiology 41, 71-90, 2016 | 212 | 2016 |
| Testicular microlithiasis: prospective analysis of prevalence and associated tumor WD Middleton, SA Teefey, CS Santillan Radiology 224 (2), 425-428, 2002 | 150 | 2002 |
| Contrast enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS®): the official version by the American College of Radiology (ACR) Y Kono, A Lyshchik, D Cosgrove, CF Dietrich, HJ Jang, TK Kim, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (01), 85-86, 2017 | 140 | 2017 |
| Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging M Tanabe, A Kanki, T Wolfson, EAC Costa, A Mamidipalli, MPFD Ferreira, ... Radiology 281 (1), 129-139, 2016 | 102 | 2016 |
| Computed tomography of small bowel obstruction CS Santillan Radiologic Clinics 51 (1), 17-27, 2013 | 78 | 2013 |
| Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation AJF Coimbra, J Rimola, S O'Byrne, TT Lu, T Bengtsson, A De Crespigny, ... Alimentary pharmacology & therapeutics 43 (1), 61-72, 2016 | 71 | 2016 |
| LI-RADS® ancillary features on CT and MRI V Chernyak, A Tang, M Flusberg, D Papadatos, B Bijan, Y Kono, ... Abdominal Radiology 43, 82-100, 2018 | 67 | 2018 |
| Development and validation of a magnetic resonance index for assessing fistulas in patients with Crohn’s disease P Hindryckx, V Jairath, G Zou, BG Feagan, WJ Sandborn, J Stoker, ... Gastroenterology 157 (5), 1233-1244. e5, 2019 | 65 | 2019 |
| LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents C Santillan, K Fowler, Y Kono, V Chernyak Abdominal Radiology 43, 75-81, 2018 | 65 | 2018 |
| The development of a magnetic resonance imaging index for fistulising Crohn's disease MA Samaan, CAJ Puylaert, BG Levesque, GY Zou, L Stitt, SA Taylor, ... Alimentary pharmacology & therapeutics 46 (5), 516-528, 2017 | 61 | 2017 |
| Reliability of measuring ileo-colonic disease activity in Crohn’s disease by magnetic resonance enterography V Jairath, I Ordas, G Zou, J Panes, J Stoker, SA Taylor, C Santillan, ... Inflammatory bowel diseases 24 (2), 440-449, 2018 | 55 | 2018 |
| LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas RC Jha, DG Mitchell, JC Weinreb, CS Santillan, BM Yeh, R Francois, ... American Journal of Roentgenology 203 (1), W48-W69, 2014 | 55 | 2014 |
| Understanding LI-RADS: a primer for practical use CS Santillan, A Tang, I Cruite, A Shah, CB Sirlin Magnetic Resonance Imaging Clinics 22 (3), 337-352, 2014 | 53 | 2014 |
| LI-RADS® algorithm: CT and MRI V Chernyak, CS Santillan, D Papadatos, CB Sirlin Abdominal Radiology 43, 111-126, 2018 | 50 | 2018 |
| LI-RADS categories: concepts, definitions, and criteria C Santillan, V Chernyak, C Sirlin Abdominal Radiology 43, 101-110, 2018 | 46 | 2018 |
| LI‐RADS 2017: an update AZ Kielar, V Chernyak, MR Bashir, RK Do, KJ Fowler, DG Mitchell, ... Journal of Magnetic Resonance Imaging 47 (6), 1459-1474, 2018 | 45 | 2018 |
| Hepatocarcinogenesis and Li-rads KH Narsinh, J Cui, D Papadatos, CB Sirlin, CS Santillan Abdominal Radiology 43, 158-168, 2018 | 42 | 2018 |
| Cirrhotic liver: What's that nodule? The LI‐RADS approach A Shah, A Tang, C Santillan, C Sirlin Journal of Magnetic Resonance Imaging 43 (2), 281-294, 2016 | 39 | 2016 |
